Factor This Power Engineering
Live Events
DTECH⢠Events
POWERGEN®
Calendar
Resource Center
Webinars
Podcasts
White Papers
Contribute Content
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Project Development
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Resource Center
Webinars
Podcasts
Whitepapers
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cel-Sci Corporation Common Stock
(NY:
CVM
)
1.600
+0.150 (+10.34%)
Streaming Delayed Price
Updated: 2:39 PM EDT, May 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cel-Sci Corporation Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
CEL-SCI Reports Fiscal First Quarter 2026 Results
February 18, 2026
From
CEL-SCI Corporation
Via
Business Wire
Why DID CVM Shares Rally Over 7% Today?
↗
January 26, 2026
Via
Stocktwits
CEL-SCI Reports Fiscal 2025 Results
December 29, 2025
From
CEL-SCI Corporation
Via
Business Wire
Retail Buzz Builds Around Cel-Sci Stock Ahead Of Saudi Ruling On Cancer Drug Multikine
↗
October 15, 2025
Via
Stocktwits
CEL-SCI Announces Closing of $10 Million Public Offering
August 29, 2025
From
CEL-SCI Corporation
Via
Business Wire
Thursday's session: top gainers and losers
↗
August 28, 2025
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
August 28, 2025
Via
Benzinga
Let's take a look at the stocks that are in motion in today's session.
↗
August 28, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
The market is filled with gapping stocks in Thursday's session.
↗
August 28, 2025
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
August 28, 2025
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 28, 2025
Via
Benzinga
Stock Market Today: Nvidia Drags Down Nasdaq Futures—Dollar General, Dell, Best Buy In Focus
↗
August 28, 2025
U.S. stock futures were swinging on Thursday following Wednesday's advances. Futures of major benchmark indices were largely mixed.
Via
Benzinga
Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
↗
August 28, 2025
Via
Benzinga
Why Is CEL-SCI Stock Crashing After-Hours?
↗
August 28, 2025
CEL-SCI's shares dropped 38.19% after announcing a $10 million public offering priced below market value to fund its cancer immunotherapy development.
Via
Benzinga
CEL-SCI Announces Pricing of $10 Million Public Offering
August 27, 2025
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Announces Proposed Public Offering
August 27, 2025
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results
August 14, 2025
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline
August 13, 2025
From
CEL-SCI Corporation
Via
Business Wire
Which stocks are experiencing notable movement on Wednesday?
↗
July 30, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 30, 2025
Via
Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
↗
July 30, 2025
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules
July 14, 2025
From
CEL-SCI Corporation
Via
Business Wire
Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
July 14, 2025
Via
Benzinga
Why Datavault AI Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
↗
July 14, 2025
Via
Benzinga
Topics
Artificial Intelligence
Which stocks are moving on Friday?
↗
July 11, 2025
Stay up-to-date with the latest market trends in the middle of the day on Friday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
CEL-SCI Stock Soars On Imminent Partnership With Saudi Arabian Pharma Company For Cancer Drug: Retail’s Thrilled
↗
July 11, 2025
The formal agreement is expected to be signed with the Saudi pharmaceutical partner in the coming weeks, CEL-SCI said.
Via
Stocktwits
CEL-SCI Announces Pricing of $5.7 Million Offering Priced At-the-Market Under NYSE American Rules
July 11, 2025
From
CEL-SCI Corporation
Via
Business Wire
There are notable gap-ups and gap-downs in today's session.
↗
July 11, 2025
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
CEL-SCI to Sign Partnership Agreement With Leading Saudi Arabian Pharma Company for Multikine in the Treatment of Head & Neck Cancer
July 11, 2025
From
CEL-SCI Corporation
Via
Business Wire
FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients
June 18, 2025
From
CEL-SCI Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
